Sertedaki Amalia, Papadimitriou Anastasios, Voutetakis Antony, Dracopoulou Maria, Maniati-Christidi Maria, Dacou-Voutetakis Catherine
Laboratory of Molecular Endocrinology, First Department of Pediatrics, Athens University, School of Medicine, Aghia Sophia Children's Hospital, Athens, Greece.
Pediatr Res. 2002 Dec;52(6):935-41. doi: 10.1203/00006450-200212000-00020.
Isolated congenital hypothyroidism resulting from mutation of the TSH beta-subunit gene, has rarely been reported. In the present article, we report a new mutation (C85R) in exon 3 of the TSH beta-subunit gene in one sporadic case and the mutation Q49stop in two siblings with congenital hypothyroidism. The novel mutation is a T to C transition at codon 85, resulting in a change of cysteine to arginine (C85R) of the ss-subunit. Because the cysteine residues of all glycoproteins are highly conserved, this mutation is expected to result in conformational changes of the ss-subunit, rendering it incapable to form a functional heterodimer with the alpha-subunit. The second mutation described is a C to T transition resulting in a premature stop at codon 49 (Q49stop), leading to the formation of a truncated protein. Although the two siblings reported herein carried the same mutation, they had slightly modified clinical and biochemical phenotype. The mutation C85R and the previously described E11stop have, thus far, exclusively been detected in Greek patients. The Q49stop mutation initially detected in Greek patients was subsequently identified in an Egyptian girl and most recently in two Turkish siblings. These three reports possibly indicate the presence of a mutational hot spot on the TSH beta-subunit gene. Hence, with the novel mutation herein reported, a total of five mutations of the TSH beta-subunit gene are recognized as a cause of low-TSH congenital hypothyroidism worldwide.
由促甲状腺激素β亚基基因突变导致的孤立性先天性甲状腺功能减退症鲜有报道。在本文中,我们报告了1例散发性病例促甲状腺激素β亚基基因第3外显子的一个新突变(C85R),以及2例先天性甲状腺功能减退症同胞中的Q49stop突变。该新突变是密码子85处的T到C转换,导致β亚基的半胱氨酸变为精氨酸(C85R)。由于所有糖蛋白的半胱氨酸残基高度保守,预计该突变会导致β亚基的构象变化,使其无法与α亚基形成功能性异源二聚体。所描述的第二个突变是C到T转换,导致密码子49处提前终止(Q49stop),从而形成截短蛋白。尽管本文报道的这2例同胞携带相同突变,但他们的临床和生化表型略有改变。迄今为止,C85R突变和先前描述的E11stop突变仅在希腊患者中检测到。最初在希腊患者中检测到的Q49stop突变随后在1名埃及女孩中被发现,最近在2例土耳其同胞中也被发现。这3篇报道可能表明促甲状腺激素β亚基基因上存在一个突变热点。因此,加上本文报道的新突变,促甲状腺激素β亚基基因的5种突变在全球范围内被认为是低促甲状腺激素先天性甲状腺功能减退症的病因。